CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $697,937
- in 4 filings, $698K under 10b5-1 plans
Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-07 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Shares withheld for taxes | −368 | $23.50 | $9K | 882 |
| 2021-06-07 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Exercise or conversion · Restricted Stock Unit Award | −1,250 | 0 | ||
| 2021-06-07 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Exercise or conversion | +13,500 | $16.55 | $223K | 88,097 |
| 2021-06-07 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Sale | −13,500 | $24.00 | $324K | 74,597 |
| 2021-06-07 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Exercise or conversion · Employee Stock Option (Right to Buy) | −13,500 | 27,500 | ||
| 2021-06-07 | ANSTICE DAVID W Director | Exercise or conversion | +5,000 | $14.60 | $73K | 78,081 |
| 2021-06-07 | ANSTICE DAVID W Director | Sale | −5,000 | $24.00 | $120K | 73,081 |
| 2021-06-07 | ANSTICE DAVID W Director | Exercise or conversion · Non Qualified Stock Option (Right to Buy) | −5,000 | 20,000 | ||
| 2021-06-05 | Nichols Christian Todd SVP, Chief Commercial Officer | Exercise or conversion | +3,500 | 8,503 | ||
| 2021-06-05 | Nichols Christian Todd SVP, Chief Commercial Officer | Shares withheld for taxes | −1,029 | $23.08 | $24K | 7,474 |
| 2021-06-05 | Nichols Christian Todd SVP, Chief Commercial Officer | Exercise or conversion · Restricted Stock Unit Award | −3,500 | 7,000 | ||
| 2021-05-20 | Wysenski Nancy Director | Exercise or conversion | +6,104 | 6,104 | ||
| 2021-05-20 | Wysenski Nancy Director | Shares withheld for taxes | −1,404 | $21.92 | $31K | 4,700 |
| 2021-05-20 | Wysenski Nancy Director | Exercise or conversion · Restricted Stock Unit Award | −6,104 | 0 | ||
| 2021-05-20 | Wilson Frank Anders Director | Exercise or conversion | +6,104 | 6,104 | ||
| 2021-05-20 | Wilson Frank Anders Director | Shares withheld for taxes | −1,404 | $21.92 | $31K | 4,700 |
| 2021-05-20 | Wilson Frank Anders Director | Exercise or conversion · Restricted Stock Unit Award | −6,104 | 0 | ||
| 2021-05-20 | snyderman nancy lynn MD Director | Exercise or conversion | +6,104 | 6,104 | ||
| 2021-05-20 | snyderman nancy lynn MD Director | Shares withheld for taxes | −1,404 | $21.92 | $31K | 4,700 |
| 2021-05-20 | snyderman nancy lynn MD Director | Exercise or conversion · Restricted Stock Unit Award | −6,104 | 0 |
Page 62 of 75 · 1,492 trades